Page last updated: 2024-11-02

pioglitazone and Corneal Opacity

pioglitazone has been researched along with Corneal Opacity in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Corneal Opacity: Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uchiyama, M1
Shimizu, A1
Masuda, Y1
Nagasaka, S1
Fukuda, Y1
Takahashi, H1

Other Studies

1 other study available for pioglitazone and Corneal Opacity

ArticleYear
An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.
    Molecular vision, 2013, Volume: 19

    Topics: Alkalies; Animals; Burns, Chemical; Chemokines; Collagen Type III; Cornea; Corneal Neovascularizatio

2013